Company Filing History:
Years Active: 1998
Title: David Vandenbergh: Innovator in Dopamine Transporter Research
Introduction
David Vandenbergh is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of neuroscience, particularly in understanding the human dopamine transporter. His work has implications for behavioral disorders and their underlying genetic factors.
Latest Patents
David Vandenbergh holds a patent for the "Sequence of human dopamine transporter cDNA." This patent describes the cloning and characterization of a human dopamine transporter (HUDAT) cDNA. The research includes RFLP analysis to determine the distribution of HUDAT alleles across two ethnic backgrounds. Furthermore, it discusses the association between HUDAT alleles and behavioral disorders that have altered HUDAT expression as a basis for their etiology. Methods for evaluating the expression of HUDAT are also described in this patent.
Career Highlights
David Vandenbergh is affiliated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding of genetic factors in behavioral health. He has dedicated his career to research that bridges genetics and psychology.
Collaborations
David has collaborated with George R Uhl, a fellow researcher in the field. Their partnership has contributed to the depth and breadth of research in dopamine transporters and their implications for health.
Conclusion
David Vandenbergh's innovative work in dopamine transporter research highlights the intersection of genetics and behavioral health. His contributions continue to influence the scientific community and pave the way for future discoveries.